Term ended May 28, 2023 · Medium confidence
20-year base term ended May 28, 2023
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 7,491,403), so the cap could be lower.
May 28, 2003
May 28, 2023
Apr 6, 2010
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts May 28, 2003, when application 10/446,562, the earliest non-provisional in its chain, was filed (this one was filed Apr 22, 2005) | May 28, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,491,403) | resolves to May 28, 2023, no earlier than this term, so no change | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | May 28, 2023 | Medium confidence |
This family
| US 7,459,164 | Term ended Jul 2025 | Jul 2025 |
| US 7,491,403 | Term ended no later than Dec 2023 | no later than Dec 2023 |
| US 7,691,394 | this patent May 2023 | May 2023 |
| Application PCT/US2006/015459 | PCT application no patent term | no patent term |
| US 8,580,745 | Lapsed on the fee record Nov 2025 | Nov 2025 |
| US 8,241,640 | In force Jan 2027 | Jan 2027 |
| US 8,679,486 | Term ended May 2023 | May 2023 |
| Application 14/225,011 | Abandoned not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 12, 2010 Reel 23764, frame 800 | Borodic, Gary E. | Botulinum Toxin Research Associates, Inc. | Assignment of Assignor's Interest |
| Jun 3, 2016 Reel 38870, frame 160 | Botulinum Toxin Research Associates, Inc. | Revance Therapeutics, Inc. | Assignment of Assignor's Interest |
| Mar 18, 2022 Reel 59437, frame 654 | Revance Therapeutics, Inc. | Athyrium Buffalo LP | Security Interest |
| Feb 7, 2025 Reel 70153, frame 630 | Athyrium Buffalo LP | Revance Therapeutics, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
A terminal disclaimer resolved from the filed document, referencing US 7,491,403, ends no earlier than this term, so it caps nothing.